Ganglioside antibodies in schizophrenia and major depression.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Biological Psychiatry

• Publication date

  1992-10-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0006-3223(92)90304-IPMID 1457628
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoglobulins, autoantibodies and other serum protein fractions in psychiatric disorders

  2004cited by this paper
• Cerebrospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis.

  1991cited by this paper
• Depression, the immune system, and health and illness. Findings in search of meaning.

  1991cited by this paper
• Anticerebral antibodies in functional psychoses.

  1991cited by this paper
• Autoantibodies to brain lipids in schizophrenia.

  1990cited by this paper
• Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.

  1989cited by this paper
• Viruses, Immunity and Mental Disorder

  1989cited by this paper
• Is schizophrenia a viral or immunologic disorder?

  1986cited by this paper
• Report of a workshop: epidemiology of esophageal cancer.

  1982cited by this paper

• Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.

  2014cites this paper
• A systematic, quantitative review of blood autoantibodies in schizophrenia.

  2013cites this paper
• Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis

  2009cites this paper
• The Case for Autoimmunity in the Etiology of Schizophrenia

  2008cites this paper
• Schizophrenia and Immune Responses

  2008cites this paper
• Bipolar Disorder: not only in the Brain - immunological aspects

  2006cites this paper
• Immune dysregulation and self‐reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?

  2005cites this paper
• Immunity and schizophrenia: autoimmunity, cytokines, and immune responses.

  2002cites this paper
• Review of immunological and immunopathological findings in schizophrenia.

  2001cites this paper
• Autoantibody disturbances in affective disorders: a function of age and gender?

  1999cites this paper
• Effects of Clozapine on In Vitro Immune Parameters: A Longitudinal Study in Clozapine-Treated Schizophrenic Patients

  1998cites this paper
• Gangliosides and autoimmune diabetes.

  1997cites this paper